Lupin in Focus After Launching Formoflo-G MDI for COPD; What to Watch | 8 October 2026
Lupin Limited launches Formoflo-G MDI, the world’s first fixed-dose triple combination drug for COPD in India. Check pre-market news and technical context.
Dated LUPIN company news, share-price movements and research from WittyTrades.
Lupin Limited launches Formoflo-G MDI, the world’s first fixed-dose triple combination drug for COPD in India. Check pre-market news and technical context.
LUPIN share price fell 0.81% to ₹2,012.90 today. See why LUPIN is falling, volume context, company developments and what to watch next.
Lupin shares gained 0.91% to ₹2029.30 on higher volume as sector benchmarks advanced. Read the latest updates, volume analysis, and market context.